NATURAL CAPSULES
|
NATURAL CAPSULES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.60 | 5.95 | 19.89 | 19.56 | 10.99 |
| CEPS(Rs) | 9.41 | 15.24 | 27.66 | 27.03 | 14.76 |
| DPS(Rs) | - | - | 1.00 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 224.86 | 218.27 | 132.85 | 118.34 | 99.63 |
| Tax Rate(%) | 77.88 | 31.03 | 26.19 | 28.23 | 24.50 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 10.42 | 11.86 | 19.91 | 17.98 | 13.96 |
| EBIT Margin(%) | 5.51 | 8.57 | 16.66 | 15.89 | 12.20 |
| Pre Tax Margin(%) | 1.65 | 5.18 | 14.50 | 14.35 | 11.51 |
| PAT Margin (%) | 0.36 | 3.57 | 10.70 | 10.30 | 8.69 |
| Cash Profit Margin (%) | 5.75 | 9.15 | 14.88 | 14.03 | 14.11 |
| Performance Ratios | |||||
| ROA(%) | 0.16 | 1.67 | 8.14 | 10.65 | 8.05 |
| ROE(%) | 0.28 | 3.40 | 17.89 | 19.18 | 11.74 |
| ROCE(%) | 2.87 | 5.00 | 16.18 | 20.75 | 14.52 |
| Asset Turnover(x) | 0.43 | 0.47 | 0.76 | 1.03 | 0.93 |
| Sales/Fixed Asset(x) | 0.65 | 0.99 | 1.32 | 1.36 | 1.02 |
| Working Capital/Sales(x) | 5.72 | 3.29 | 4.99 | 4.38 | 4.88 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.53 | 1.01 | 0.76 | 0.74 | 0.98 |
| Receivable days | 125.88 | 125.17 | 83.04 | 71.61 | 130.95 |
| Inventory Days | 47.99 | 32.74 | 14.22 | 15.12 | 27.29 |
| Payable days | 148.15 | 134.19 | 100.67 | 97.82 | 112.34 |
| Valuation Parameters | |||||
| PER(x) | 308.53 | 51.33 | 19.76 | 23.63 | 8.03 |
| PCE(x) | 19.57 | 20.05 | 14.21 | 17.10 | 5.98 |
| Price/Book(x) | 0.82 | 1.40 | 2.96 | 3.91 | 1.08 |
| Yield(%) | - | - | 0.25 | 0.22 | 0.93 |
| EV/Net Sales(x) | 1.71 | 2.45 | 2.63 | 2.75 | 0.94 |
| EV/Core EBITDA(x) | 15.67 | 17.31 | 12.64 | 14.01 | 6.33 |
| EV/EBIT(x) | 30.98 | 28.58 | 15.81 | 17.30 | 7.73 |
| EV/CE(x) | 0.86 | 1.22 | 2.07 | 2.26 | 1.04 |
| M Cap / Sales | 1.13 | 1.83 | 2.11 | 2.40 | 0.84 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.87 | -9.84 | 27.62 | 69.86 | 29.18 |
| Core EBITDA Growth(%) | -16.12 | -38.80 | 35.54 | 124.10 | 84.85 |
| EBIT Growth(%) | -29.98 | -53.61 | 33.78 | 121.35 | 325.70 |
| PAT Growth(%) | -88.88 | -69.89 | 32.57 | 101.29 | 706.04 |
| EPS Growth(%) | -89.97 | -70.08 | 1.66 | 78.04 | 698.55 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.45 | 0.54 | 0.78 | 0.63 | 0.16 |
| Current Ratio(x) | 1.30 | 1.62 | 1.52 | 1.69 | 1.49 |
| Quick Ratio(x) | 1.04 | 1.37 | 1.38 | 1.59 | 1.29 |
| Interest Cover(x) | 1.43 | 2.53 | 7.70 | 10.31 | 17.84 |
| Total Debt/Mcap(x) | 0.54 | 0.38 | 0.26 | 0.12 | 0.14 |
Compare Financial Ratios of peers of NATURAL CAPSULES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATURAL CAPSULES | ₹184.0 Cr | 3.2% | 1.1% | -37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
NATURAL CAPSULES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATURAL CAPSULES | 3.2% |
1.1% |
-37.3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses
